GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases

Clinical trial NCT07021209 · RECRUITING

Trial details

NCT number: NCT07021209
Sponsor: Grit Biotechnology
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neurological Autoimmune Diseases

Start date: 2025-01-14
Primary completion: 2028-01-13
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.